Health Technology · Pharmaceuticals: Major · NSE: VAISHALI · data 2026-10-09
Vaishali Pharma Ltd.
Health check: Average (5.3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹7.92
Market cap
₹86 cr
P/E
24.1
P/B
—
ROE
6.2%
ROCE
3.6%
Debt / equity
0.27
Dividend yield
0.00%
1-year return
-28.6%
52-week high
₹11.24
52-week low
₹4.75
Operating margin
3.4%
Growth
| Revenue (last 12 months) | ₹108 cr |
| Net profit (last 12 months) | ₹4 cr |
| Sales growth, 3 years (yearly) | 15.8% |
| Profit growth, 3 years (yearly) | -14.2% |
Chart patterns
- Double top — forming (key level ₹7.75)
- Descending triangle — breakdown (key level ₹8.01)
- Head and shoulders — forming (key level ₹7.75)
Similar companies
Makers Laboratories Ltd (MAKERSL) · Sotac Pharmaceuticals Limited (SOTAC) · Vilin Bio Med Ltd. (VILINBIO) · Sunil Healthcare Ltd. (SUNLOC) · Zenith Drugs Ltd. (ZENITHDRUG)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VAISHALI in NSE Scanner →